Press releases

2018

2018

05 nov, 2018 Bioscience Division revenues drive operational growth to 9.6% in the third quarter and boost net profits to Euros 468 million

27 oct, 2018 Grifols demonstrates a significant reduction (61%) in the progression of moderate Alzheimer’s disease using its AMBAR treatment protocol

07 sep, 2018 Grifols and the European Investment Bank sign an Euros 85 million long-term loan to support its R+D+i initiatives

01 aug, 2018 Grifols expands its plasma collection network by acquiring 24 Biotest centers in the United States

27 jul, 2018 Grifols increases net profits by 15% to EUR 319 million, with sustained operational revenue growth of 7%

16 jul, 2018 Grifols has been included in the FTSE4Good Index

25 may, 2018 Grifols culminates a year of growth and approves the distribution of a record EUR 265 million in dividends

23 may, 2018 Grifols publishes its 2017 Corporate Responsibility Report as part of its commitment to transparency

10 may, 2018 Grifols reaches an agreement with Boya Bio-Pharmaceutical to open plasma collection centers in China

03 may, 2018 Grifols increases its net profit by 7% to Euros 143 million and delivers significant growth in organic sales

20 mar, 2018 Grifols expands and diversifies its plasma collection network with the acquisition of 35 donation centers in Germany from Aton

28 feb, 2018 Grifols revenues exceed EUR 4,300 million and reported profit reaches EUR 663 million

26 jan, 2018 Grifols acquires a 51% in the U.S. technology firm MedKeeper for USD 98 million

2017
2016
2015
2014
2013
Previous

2010

15 dec, 2010 Grifols obtains EMA license to market its IVIG, Flebogamma® DIF, at 10% concentration

24 nov, 2010 Grifols signs term loan agreements related to Talecris acquisition for USD 3.4 billion

23 nov, 2010 Grifols announces US launch of Flebogamma DIF 10% IVIG

04 nov, 2010 Grifols' turnover increased by 7.1% in the first nine months of 2010 to 738.8MM Euros

28 sep, 2010 Grifols continues investing to boost its Diagnostic division

15 sep, 2010 Grifols expects to close for an amount of USD1.5B the first tranche of the syndicated Financing to acquire Talecris

02 sep, 2010 Grifols Obtains FDA Approval for Flebogamma® DIF 10 % IVIG

29 jul, 2010 Grifols sales in the first half of 2010 increase 3.7% up to 487.8 million Euros

20 jul, 2010 Grifols obtains its first crédit rating from Standard & Poor's and Moody's

24 jun, 2010 Progenika Biopharma grants Grifols World-wide distribution of its Bloodchip® genotyping test for blood donors

21 jun, 2010 Grifols holds its Annual General Meeting

07 jun, 2010 Grifols to acquire Talecris Biotherapeutics creating a world leading provider of life-saving plasma protein therapies

02 jun, 2010 Grifols initiates clinical investigation of a new treatment protocol for Alzheimer's disease

20 may, 2010 Grifols agreement with Pharmalink to acquire the intellectual property for the treatment of Post-Polio Syndrome (PPS)

28 apr, 2010 Sales of plasma products have grown by 8.2% at constant currency, reaching 184.6 million euros inthe first quarter of 2010 and driving the group's turnover

25 feb, 2010 Grifols' net profit increased by 21.6% in 2009 to 148 MM euros

2009

26 may, 2012 Cerus and Grifols Extend INTERCEPT Blood System Distribution to Italy

23 dec, 2009 Grifols obtains FDA approval for a new in filling area in its Albumin plant in LA

16 dec, 2009 Grifols and financial institutions unanimously agree the novation of the syndicated facility

09 dec, 2009 Grifols builds a new solutions factory in Murcia

04 nov, 2009 Grifols reports a 14.9% increase in revenue in the first nine months of 2009 to 689.6 MM euros

26 oct, 2009 Spanish minister of Industry, Tourism and Trade visits Grifols' facilities in LA.

16 oct, 2009 Grifols to break ground on a new testing laboratory in San Marcos, Texas (US).

07 oct, 2009 Grifols completes its USD600 million corporate bond issue in the US

21 sep, 2009 Grifols publishes interim results of its clinical trial on Alzheimer's disease

27 jul, 2009 Grifols' net profit rose 31.4% in the first half of 2009 to 81.7 MM euros

30 jun, 2009 Health Robotics and Grifols sign a collaboration agreement

28 may, 2009 The shares of Grifols will be traded in the United States through ADRs

15 may, 2009 Grifols holds its Annual General Meeting

28 apr, 2009 Grifols' net profit rose 33.8 % in the first quarter of 2009 to 41.6 million euros

03 mar, 2009 Grifols acquires control over a Swiss and Australian group through a €25 million investment

26 feb, 2009 Grifols' net profit advanced 38.7% in 2008 to 121.7 million euros.

28 jan, 2009 Grifols Academy of Plasmapheresis opens in US

19 jan, 2009 Health Robotics and Grifols sign a collaboration agreement



Category




Year